Log in to save to my catalogue

A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF(V600E) colo...

A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF(V600E) colo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2727082637

A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF(V600E) colorectal tumors

About this item

Full title

A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF(V600E) colorectal tumors

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

Journal title

bioRxiv, 2022-10

Language

English

Formats

Publication information

Publisher

Cold Spring Harbor: Cold Spring Harbor Laboratory Press

More information

Scope and Contents

Contents

BRAF(V600E) mutation confers a poor prognosis in metastatic colorectal cancer (CRC) despite combinatorial targeted therapies based on the latest understanding of signaling circuitry. To identify parallel resistance mechanisms induced by BRAF/MEK/EGFR co-targeting, we used a high throughput kinase activity mapping platform. We found that SRC kinases...

Alternative Titles

Full title

A reversible SRC-relayed COX2-inflammatory program drives therapeutic resistance in BRAF(V600E) colorectal tumors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2727082637

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2727082637

Other Identifiers

DOI

10.1101/2022.10.20.512885